Clinical Trial Update: The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study [Phase 4]

View source ↗

Summary

A randomized prospective Phase 4 study evaluating medical expulsive therapy with Alfuzosin XL 10 mg once daily for distal ureterolithiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Ureterolithiasis

Drugs mentioned

• Alfuzosin XL (alfuzosin)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Distal Ureterolithiasis | Phase 4 | Status: UNKNOWN